Binocular visual function after staged implantation of extended-depth-of-focus intraocular lens targeting emmetropia and -0.5 diopter: A prospective comparison.
Aged
Aged, 80 and over
Astigmatism
/ physiopathology
Cataract Extraction
Emmetropia
/ physiology
Female
Humans
Lens Implantation, Intraocular
/ methods
Male
Middle Aged
Multifocal Intraocular Lenses
Patient Preference
Patient Satisfaction
Presbyopia
/ physiopathology
Prospective Studies
Time Factors
Vision, Binocular
/ physiology
Visual Acuity
/ physiology
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2020
2020
Historique:
received:
15
06
2020
accepted:
09
08
2020
entrez:
26
8
2020
pubmed:
26
8
2020
medline:
21
10
2020
Statut:
epublish
Résumé
The prospective comparative case series aimed to evaluate the binocular uncorrected visual acuities (BUCVAs) after staged implantations of extended-depth-of-focus intraocular lenses (EDOF IOLs) targeting emmetropia and -0.5 diopter (D). Diffractive EDOF IOLs with an add power of +1.75 D were implanted in the first eyes targeting emmetropia or -0.5 D according to the patients' preferences, then the targets for the second eyes were determined 1 week or longer after the implantation. IOL powers were determined with the SRK/T formula. Consequently, the subjects were divided into 3 groups: those with emmetropia targeted bilaterally (group EE, 22 patients), those with -0.5 D targeted bilaterally (group MM, 21 patients), and those with monovision of emmetropia and -0.5 D (group EM, 21 patients). Manifest refraction spherical equivalent (MRSE), BUCVA from 0.3 to 5 meters, spectacle use, and questionnaire regarding photic symptoms and patient satisfaction were assessed 3 months postoperatively. No significant differences were seen in the mean BUCVAs at any distance (P > 0.23), spectacle use (P = 0.13), or photic symptoms and patient satisfaction (P>0.65). When the EE and MM groups were assigned based on the MRSE, the EE group was better at 5 m (P = 0.005) while the MM group at 0.5 m (P = 0.031). The effect of different targeted refractions was not identified due to insufficient accuracy in the use of the SRK/T power calculation.
Identifiants
pubmed: 32841287
doi: 10.1371/journal.pone.0238135
pii: PONE-D-20-18251
pmc: PMC7447018
doi:
Types de publication
Comparative Study
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0238135Déclaration de conflit d'intérêts
The authors have read the journal policies and the authors have the following competing interests to declare: The study was supported by Johnson & Johnson Surgical Vision. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
Références
Nippon Ganka Gakkai Zasshi. 1980 Oct 10;84(10):1619-28
pubmed: 7257979
Biomed Opt Express. 2017 Aug 31;8(9):4294-4309
pubmed: 28966865
J Cataract Refract Surg. 2012 Jul;38(7):1181-6
pubmed: 22727287
Graefes Arch Clin Exp Ophthalmol. 2019 May;257(5):863-875
pubmed: 30627791
Clin Ophthalmol. 2018 Nov 12;12:2305-2312
pubmed: 30518994
Jpn J Ophthalmol. 2018 Mar;62(2):226-230
pubmed: 29264862
J Cataract Refract Surg. 2016 Oct;42(10):1490-1500
pubmed: 27839605
Asia Pac J Ophthalmol (Phila). 2017 Jul-Aug;6(4):339-349
pubmed: 28780781
Cochrane Database Syst Rev. 2016 Dec 12;12:CD003169
pubmed: 27943250
J Cataract Refract Surg. 2016 Sep;42(9):1268-1275
pubmed: 27697244
Am J Ophthalmol. 2019 Mar;199:223-229
pubmed: 30552894
J Refract Surg. 2016 Jul 1;32(7):436-42
pubmed: 27400074
Ophthalmology. 2018 Feb;125(2):169-178
pubmed: 28951074
J Cataract Refract Surg. 2019 Oct;45(10):1398-1403
pubmed: 31444080
Surv Ophthalmol. 2017 Sep - Oct;62(5):611-634
pubmed: 28366683
J Refract Surg. 2017 Apr 1;33(4):218-222
pubmed: 28407160